Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

阿尔茨海默病和痴呆症:诊断、评估和疾病监测

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring》是由Wiley-Blackwell出版社创办的英文国际期刊(ISSN: 2352-8729),该期刊长期致力于临床神经病学领域的创新研究,主要研究方向为Multiple。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA未开放获取模式(OA占比%),以发表临床神经病学领域等方向的原创性研究为核心(研究类文章占比95.98%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在174篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring审稿周期约为8 Weeks。该刊近年未被列入国际预警名单,年发文量约174篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 174 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
CLINICAL NEUROLOGY 临床神经病学 NEUROSCIENCES 神经科学
2区 2区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
CLINICAL NEUROLOGY 临床神经病学 NEUROSCIENCES 神经科学
3区 3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY ESCI Q1 41 / 296

86.3

学科:NEUROSCIENCES ESCI Q1 70 / 330

78.9

学科:CLINICAL NEUROLOGY ESCI Q1 48 / 296

83.95

学科:NEUROSCIENCES ESCI Q1 52 / 330

84.39

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY ESCI Q1 51 / 277

81.8

学科:NEUROSCIENCES ESCI Q2 86 / 310

72.4

学科:CLINICAL NEUROLOGY ESCI Q1 56 / 278

80.04

学科:NEUROSCIENCES ESCI Q1 76 / 310

75.65

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:7.1 SJR:1.774 SNIP:1.279
学科类别 分区 排名 百分位
大类:Medicine 小类:Psychiatry and Mental Health Q1 85 / 580

85%

大类:Medicine 小类:Neurology (clinical) Q1 72 / 403

82%

期刊发文

  • A prospective real-world study of the efficacy and safety of aducanumab in China: Focus on early-onset and autosomal dominant Alzheimer's diseas

    Author: Xiao, Jinwen; Li, Binyin; Li, Biao; Wang, Jintao; Tang, Ran; Gao, Chao; Che, Xiangqian; Xu, Xiaomeng; Chen, Shengdi; Ren, Rujing; Wang, Gang

    Journal: ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING. 2026; Vol. 18, Issue 2, pp. -. DOI: 10.1002/dad2.70328

  • Stigma, isolation, and depression in Chinese and Korean American dementia caregiver

    Author: Qi, Xiang; Ko, Eunjung; Ruan, Jia Yin; Wang, Jing; Leong, Tek; Jung, Ju Hye; Su, Jin; Pei, Yaolin; Mittelman, Mary S.; Wu, Bei

    Journal: ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING. 2026; Vol. 18, Issue 2, pp. -. DOI: 10.1002/dad2.70272

  • Deep medullary vein abnormalities associated with cognitive function and Alzheimer's disease plasma biomarkers in dementia-free older adults: A population-based stud

    Author: Yin, Dejia; Wang, Jiafeng; Li, Chunyan; Wang, Xiaoyu; Wang, Yan; Xie, Qianqian; Tian, Na; Chen, Ziwei; Sun, Xuemin; Wang, Yongxiang; Hou, Tingting; Cong, Lin; Zhou, Li; Du, Yifeng; Song, Lin; Qiu, Chengxuan

    Journal: ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING. 2026; Vol. 18, Issue 2, pp. -. DOI: 10.1002/dad2.70320

  • Plasma glial fibrillary acidic protein as a mediator of amyloid-associated cognitive decline over 4-year follow-up in pre-dementia stage

    Author: Wei, Hongchun; Zhang, Chunhua; Wen, Puyuan; Kong, Min; Ba, Maowen

    Journal: ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING. 2026; Vol. 18, Issue 1, pp. -. DOI: 10.1002/dad2.70293

  • Alzheimer's and dementia: Diagnosis, assessment, and disease monitoring global, regional, and national burden of Alzheimer's disease and other dementias (ADODs) and their risk factors, 1990-2021: A systematic analysis for the Global Burden of Disease study 202

    Author: Wang, Fang; Li, Dongxin; Gao, Xuetian; Zhang, Xingye; Shi, Xuanying; Guo, Youquan

    Journal: ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING. 2025; Vol. 17, Issue 2, pp. -. DOI: 10.1002/dad2.70126

  • Brain-derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementi

    Author: Marotta, Cassandra; Gonzalez-Ortiz, Fernando; Turton, Michael; Zetterberg, Henrik; Harrison, Peter; Hovens, Christopher M.; Sinclair, Benjamin; O'Brien, Terence J.; Blennow, Kaj; Vivash, Lucy

    Journal: ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING. 2025; Vol. 17, Issue 2, pp. -. DOI: 10.1002/dad2.70123

  • Cerebrospinal fluid YKL-40 relates to white matter hyperintensity progression in females but not males over a 6-year perio

    Author: Peterson, Amalia J.; Sun, Yunyi; Archer, Derek B.; Adegboye, Hailey A.; Moore, Elizabeth E.; Deberghes, Isabella; Pechman, Kimberly R.; Shashikumar, Niranjana; Robb, W. Hudson; Workmeister, Abigail W.; Jackson, T. Bryan; Liu, Dandan; Dumitrescu, Logan; Davis, L. Taylor; Landman, Bennett A.; Blennow, Kaj; Zetterberg, Henrik; Hohman, Timothy J.; Jefferson, Angela L

    Journal: ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING. 2025; Vol. 17, Issue 2, pp. -. DOI: 10.1002/dad2.70110

  • Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy-confirmed cohort from Chin

    Author: Yin, Xiang-Sha; Sun, Jianru; Wang, Xue; Wu, Wei; Chen, Zhen; Zhang, Di; Xu, Yuanyuan; Chen, Yongmei; Qiu, Wenying; Qian, Xiaojing; Ni, Jun; Ma, Chao

    Journal: ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING. 2025; Vol. 17, Issue 2, pp. -. DOI: 10.1002/dad2.70100